To track the capital performance of the UK equity market as represented by the FTSE 100 Index. The investment adviser will closely replicate the index by holding principally the stocks represented therein.
Name | % Net Assets |
---|---|
BP | 9.9% |
HSBC Holdings | 8.1% |
Vodafone Group | 7.6% |
GlaxoSmithKline | 6.8% |
RBoS | 4.3% |
Shell Transport & Trading (Registered) | 3.9% |
AstraZeneca | 3.3% |
Barclays | 3.0% |
HBOS | 2.6% |
Lloyds TSB Group | 2.2% |
Key | % Net Assets |
---|---|
BP | 9.9% |
HSBC Holdings | 8.1% |
Vodafone Group | 7.6% |
GlaxoSmithKline | 6.8% |
Other | 67.6% |
Date | 25-Nov-2016 |
---|---|
NAV | 171.70p |
Currency | GBP |
Change | -0.100p |
% | -0.06% |
YTD change | 171.70p |
YTD % | n/a |
Fund Inception | 01/03/1999 |
---|---|
Fund Manager | Paul Chu |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | 3.50% |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.07 |
You are here: research